← HB870 bill details

Substantive final action

HB870

Senate Vote on HB 870 FINAL PASSAGE (#1021)

Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)

Passed Senate May 19, 2026⭐ Substantive final action

33Yea
0Nay
0Not voting
6Absent
Source provenance